BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 13685339)

  • 1. Enzymatic formation of psychotomimetic metabolites from normally occurring compounds.
    AXELROD J
    Science; 1961 Aug; 134(3475):343. PubMed ID: 13685339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.
    Barman R; Kumar Bora P; Saikia J; Konwar P; Sarkar A; Kemprai P; Proteem Saikia S; Haldar S; Slater A; Banik D
    Phytochemistry; 2024 Feb; 218():113928. PubMed ID: 38035973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
    Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
    Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota-derived psychedelics: Lessons from COVID-19.
    Sfera A; Hazan S; Kozlakidis Z; Klein C
    Adv Clin Exp Med; 2023 Apr; 32(4):395-399. PubMed ID: 36753370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N, N-dimethyltryptamine: an endogenous hallucinogen.
    Barker SA; Monti JA; Christian ST
    Int Rev Neurobiol; 1981; 22():83-110. PubMed ID: 6792104
    [No Abstract]   [Full Text] [Related]  

  • 6. The biosynthesis of dimethyltryptamine in vivo.
    Mandel LR; Prasad R; Lopez-Ramos B; Walker RW
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):47-58. PubMed ID: 14361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
    Cameron LP; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.
    Fontanilla D; Johannessen M; Hajipour AR; Cozzi NV; Jackson MB; Ruoho AE
    Science; 2009 Feb; 323(5916):934-7. PubMed ID: 19213917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N,N-dimethyltryptamine and the pineal gland: Separating fact from myth.
    Nichols DE
    J Psychopharmacol; 2018 Jan; 32(1):30-36. PubMed ID: 29095071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.
    Li J; Sun C; Cai W; Li J; Rosen BP; Chen J
    Mutat Res Rev Mutat Res; 2021; 788():108396. PubMed ID: 34893161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.
    Cumming P; Scheidegger M; Dornbierer D; Palner M; Quednow BB; Martin-Soelch C
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and synthetic biology of psychoactive natural products.
    Jamieson CS; Misa J; Tang Y; Billingsley JM
    Chem Soc Rev; 2021 Jun; 50(12):6950-7008. PubMed ID: 33908526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.
    Morales-Garcia JA; Calleja-Conde J; Lopez-Moreno JA; Alonso-Gil S; Sanz-SanCristobal M; Riba J; Perez-Castillo A
    Transl Psychiatry; 2020 Sep; 10(1):331. PubMed ID: 32989216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human indole(ethyl)amine-N-methyltransferase (hINMT) catalyzed methylation of tryptamine, dimethylsulfide and dimethylselenide is enhanced under reducing conditions - A comparison between 254C and 254F, two common hINMT variants.
    Torres B; Tyler JS; Satyshur KA; Ruoho AE
    PLoS One; 2019; 14(7):e0219664. PubMed ID: 31310642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.
    Dean JG; Liu T; Huff S; Sheler B; Barker SA; Strassman RJ; Wang MM; Borjigin J
    Sci Rep; 2019 Jun; 9(1):9333. PubMed ID: 31249368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.
    Barker SA
    Front Neurosci; 2018; 12():536. PubMed ID: 30127713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolethylamine-
    Dean JG
    Front Neurosci; 2018; 12():232. PubMed ID: 29740267
    [No Abstract]   [Full Text] [Related]  

  • 18. The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells.
    Szabo A; Kovacs A; Riba J; Djurovic S; Rajnavolgyi E; Frecska E
    Front Neurosci; 2016; 10():423. PubMed ID: 27683542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
    Szabo A
    Front Immunol; 2015; 6():358. PubMed ID: 26236313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.